Coastal Greenland : CHANGE OF DIRECTORS (in PDF)

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

沿海綠色家園有限公司*

(Incorporated in Bermuda with limited liability)

The Board announces that Mr. Cai Shaobin has tendered his resignation as an executive Director and a member of the Investment Committee with effect from 20 March 2017.

The Board announces that Dr. Li Ting has been appointed as an executive Director and a member of the Investment Committee with effect from 20 March 2017.

The board (the "Board") of directors (the "Director(s)") of Coastal Greenland Limited (the "Company", together with its subsidiaries, the "Group") announces that Mr. Cai Shaobin ("Mr. Cai") has tendered his resignation as an executive Director and a member of the investment committee of the Board (the "Investment Committee") with effect from 20 March 2017 due to his decision to devote more time to his personal endeavours.

* For identification purpose only

Mr. Cai has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders (the "Shareholders") of the Company and The Stock Exchange of Hong Kong Limited (the "Stock Exchange").

The Company would like to express its sincere gratitude to Mr. Cai for his valuable contributions to the Group during his term of office.

The Board announces that Dr. Li Ting ("Dr. Li") has been appointed as an executive Director and a member of the Investment Committee with effect from 20 March 2017.

The biographical details of Dr. Li are as follows:

Dr. Li, aged 41, graduated from Xi'an Jiaotong University in 1997 with a bachelor's degree in computer application and further obtained a master's degree and a doctorate degree in management science and engineering from Xi'an Jiaotong University in 2000 and 2005. Dr. Li also obtained a master's degree in business administration (EMBA) from China Europe International Business School in 2013.

Dr. Li first joined the Group in 2005 and has since served as the general manager of the strategic management department of Coastal Realty Investment (China) Limited from 2005 to 2011, the chairman of the southern China region of Coastal Realty Investment (China) Limited from 2012 to 2013 and the vice president and chief knowledge officer of the Company from 2012 to present. Dr. Li is mainly responsible for the Group's strategic planning, business management systems and innovative business development.

Dr. Li has entered into a service contract with the Company for a term of three years for his service as an executive Director, which shall be automatically extended for another one year upon expiration of the term of the service contract unless terminated by either party to the service contract, which requires not less than three month's length of notice. In accordance with the bye-laws of the Company, at each annual general meeting one-third of the Directors (or, if their number is not a multiple of three, the number nearest to but not less than one- third), shall retire from office by rotation provided that every Director shall be subject to retirement by rotation at least once every three years. Dr. Li is subject to retirement by rotation and re-election at the Company's annual general meetings. Dr. Li will receive a Director's remuneration of RMB1,200,000 (equivalent to approximately HK$1,344,000) per annum which is determined with reference to his duties and responsibilities with the Company, the Company's performance and the prevailing market situation. The Director's remuneration of Dr. Li will be reviewed annually by the Board with reference to his duties and responsibilities with the Company, the Company's performance and the prevailing market situation. Pursuant to the terms of the service contract, Dr. Li may receive bonus payment from the Company at the absolute discretion of the Board.

As at the date of this announcement, Dr. Li did not have any relationship with other Directors, senior management or substantial or controlling shareholders of the Company nor hold any directorship in any public companies the securities of which are listed on any securities market in Hong Kong or overseas in the past three years. As at the date of this announcement, Dr. Li holds 16,500,000 share options granted under the share option scheme adopted by the Company on 14 September 2011. Save as disclosed, he does not have, and is not deemed to have any interests or short positions in any shares, underlying shares or debentures of the Company or any of its associated corporations which is require to be disclosed under Part XV of the Securities and Future Ordinance (the "SFO") (Chapter 571 of the Law of Hong Kong) as at the date of this announcement.

There is no information relating to Dr. Li that is required to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Rules Governing the Listing of Securities on the Stock Exchange (the "Listing Rules"). Save as disclosed above, there is no other matter in relation to the appointment of Dr. Li that needs to be brought to the attention of the Shareholders and the Stock Exchange.

The Board would like to express its warmest welcome to Dr. Li in joining the Board.

After the abovementioned resignation and appointment of Directors, the Investment Committee is now composed of three executive Directors, namely Mr. Tao Lin, as the chairman of the Investment Committee, Mr. Xia Xianglong and Dr. Li.

By order of the Board

Chairman

Hong Kong, 20 March 2017

As at the date of this announcement, the Board comprises (1) Mr. Jiang Ming, Mr. Tao Lin, Mr. Xia Xianglong and Dr. Li Ting as executive Directors; (2) Mr. Lu Jiqiang and Dr. Dai Jingming as non-executive Directors; and (3) Mr. Wong Kai Cheong, Mr. Yang Jiangang and Mr. Huang Xihua as independent non-executive Directors.